Initial medical attention on patients with early-stage non-small cell lung cancer.
Chen, Xing; Gorlov, Ivan P; Ying, Jun; Merriman, Kelly W; Kimmel, Marek; Lu, Charles; Reyes-Gibby, Cielito C; Gorlova, Olga Y.
; 7(3): e32644, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22412901
Lung cancer: current therapies and new targeted treatments.
Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer.
Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Postoperative radiotherapy for non-small cell lung cancer.
Lung Cancer: A Wily Genetic Opponent.
Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.
A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.